# Dosage and PD Study of Eftrenonacog-alfa

> **NCT04590950** · — · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 15 (actual)

## Conditions studied

- Severe Haemophilia B

## Interventions

- **OTHER:** Non interventional study

## Key facts

- **NCT ID:** NCT04590950
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-18
- **Primary completion:** 2020-03-31
- **Final completion:** 2020-03-31
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2026-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04590950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04590950, "Dosage and PD Study of Eftrenonacog-alfa". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04590950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*